Immunitybio Inc
NASDAQ:IBRX
Immunitybio Inc
NASDAQ:IBRX
Price:
6.92
USD
-5.08%
Market Closed
Market Cap:
$7.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Immunitybio Inc
NASDAQ:IBRX
|
US |
|
Discovex Resources Ltd
ASX:DCX
|
AU |
|
S
|
Steakholder Foods Ltd
NASDAQ:STKH
|
IL |
|
A
|
Adocia SA
PAR:ADOC
|
FR |
|
O
|
Orezone Gold Corp
TSX:ORE
|
CA |
|
Comfortdelgro Corporation Ltd
SGX:C52
|
SG |
Wall St Price Targets
IBRX Price Targets Summary
Immunitybio Inc
Immunitybio Inc
Wall Street analysts forecast IBRX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for IBRX is 14.69 USD with a low forecast of 11.11 USD and a high forecast of 23.1 USD.
Lowest Forecast
Price Target
11.11
USD
61% Upside
Average Forecast
Price Target
14.69
USD
112% Upside
Highest Forecast
Price Target
23.1
USD
234% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IBRX's stock price target?
Price Target
14.69
USD
14.69
USD
According to Wall Street analysts, the average 1-year price target for IBRX is 14.69 USD with a low forecast of 11.11 USD and a high forecast of 23.1 USD.
What is the Revenue forecast for Immunitybio Inc?
Projected CAGR
68%
68%
Over the last 11 years, the compound annual growth rate for Revenue has been 60%. The projected CAGR for the next 8 years is 68%.
